Systems Pathophysiological Modeling of Metabolic Reprograming in Alcoholic HepatitisAlexandra Manchel1, Radhakrishnan Mahadevan2, Ramon Bataller3, Jan Hoek1, and Rajanikanth Vadigepalli1
|
Outcome of Targeting ATR in High Replication Stress Murine HCCFANG Jing1, HE Qiyuan1, PAN Long3, DONNE Romain 2, ARAUJO Joana 1, POPHILLAT Céline 1, KABORE Christelle 1, COUTY Jean-Pierre 1, ZUCMAN-ROSSI Jessica 3, LUJAMBIO Amaya 2, MORIZUR Séverine 1, and DESDOUETS Chantal 1
|
Exploring Aspirin's Role in Mitigating Liver Cancer Development: Insights from a NASH Mouse ModelNur Dianah Abu Bakar
|
CELL-TRANSPLANTATION-INDUCED REPROGRAMMING STATE IS ESSENTIAL FOR
HEPATOCYTE ENGRAFTMENTZhen Sun
|
Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): impact of the PNPLA3-I148M risk alleleMélanie Kirchmeyer1, Anthoula Gaigneaux1, Florence Servais1, Anita Arslanow2,3, Markus Casper3, Marcin Krawczyk3, Frank Lammert3,4, and Iris Behrmann1
|
Development of a precision bio-printed liver tumour patient-derived organoid platformGayatri Shirolkar1,6, Sara Pasic1,6, Jonathan Tibballs2,6, Shirley Go2,6, Rachel Way4,6, Michael Wallace2,5,6, Louise Winteringham3,6, Peter Leedman3,6, Janina Tirnitz-Parker1,3,6, and Benjamin Dwyer1,6
|
Transcriptional Master Regulators as Therapeutic Targets in Hepatocellular CarcinomaYoshinobu Saito1, Ajay Nair1, Qiuyan Sun1, Marcella Steffani1, Kirk Wangensteen2, Andrea Califano1, and Robert Schwabe1
|
Beneficial effects of hepatic cyclooxygenase-2 expression against NAFLD/NASH: a potential therapeutic targetMaría Luque-Tévar1,2, Carme Cucarella1,2, Marina Fuertes-Agudo1,2, Paloma Martín-Sanz2,3, and Marta Casado1,2
|
Identifying drivers of liver cancer using CRISPR activation screening in vivoAlexandra Vázquez Salgado1, Markcus Lee1, Shirui He2, and Kirk Wangensteen1
|
Extracellular Matrix Protein 1 and the short Peptide KTFR prevent protease-mediated Latent Transforming Growth Factor-β1 Activation, subsequent Hepatic Stellate Cell Activation and revert Liver Injury and Fibrosis following Extracellular Matrix Protein 1 KnockoutFrederik Link1, Yujia Li1, Stefan Munker2,3, Zeribe Nwosu4, Weiguo Fan5, Honglei Weng1, Matthias Ebert1,6, Steven Dooley1, and Sai Wang1
|
Epigenetic regulation by UHRF1 in the aging liverYousra Ajouaou, Filippo Macchi, Shuang Wang, and Kirsten Sadler Edepli
|
Combined high-resolution digital histomorphometry and second harmonic generation-based collagen characterization reveals spatial context in liver fibrosis and cancerThomas Sorz1,2,3, Oleksandr Petrenko1,2,3, Benedikt Simbrunner1,2,3,4, Kerstin Zinober1,3,4, Georg Semmler1,4, Philipp Königshofer1,3,4, Christopher Kaltenecker5, Frank Assen6, Benedikt Hofer1,2,3,4, Behrang Mozayani5, Renate Kain5, Wolfgang Weninger6, Michael Trauner1, Philipp Schwabl1,2,3,4, and Thomas Reiberger1,2,3,4
|
Dysregulated sphingolipid metabolism in MASH-HCCHuiping Zhou, Jing Zeng, Derrick Zhao, Xuan Wang, and Phillip Hylemon
|
Macrophage mediated senescent cell elimination in a liver cancer model in zebrafishElena Magnani, Charlene Chen, Filippo Macchi, Ian McBain, and Kirsten Sadler
|
Alpha-smooth-muscle actin represents a histologic surrogate of regressive vs. progressive cirrhosisThomas Sorz1,2,3, Benedikt Simbrunner1,2,3,4, Kerstin Zinober1,3,4, Georg Semmler1,4, Philipp Königshofer1,3,4, Christopher Kaltenecker5, Oleksandr Petrenko1,2,3, Benedikt Hofer1,2,3,4, Behrang Mozayani5, Vlad Taru1,3, Renate Kain5, Michael Trauner1, Matthias Mandorfer1,4, Philipp Schwabl1,2,3,4, and Thomas Reiberger1,2,3,4
|
Carrot Edible Exosomes Potentiates a Therapy for Hepatic Encephalopathy by Modulating Gut Microbiota and Reducing Ammonia levels Sukriti Baweja, P Debishree Subudhi, Chhagan Bihari, and Shiv Sarin
|
In Vivo Tracking and 3D Mapping of Cell Death during Liver Regeneration and CancerIvan Moya1,2 and Georg Halder2
|
Disease-specific human ECM composition and bioactivity in NASH liver fibrosisLisa Longato
|
Gut and Circulating Bacterial Vesicles and their Virulence Factors Increase with Severity of Autoimmune HepatitisSukriti Baweja, Swati Thangariyal, Chhagan Bihari, and Shiv Sarin
|
Pathway analysis including miRNA function. Artemis Hatzigeogriou, Spyros Tastsoglou, Giorgos Skoufos, Marios Miliotis, and Filippos Kardaras
|
